- US-listed companies
- Panbela Therapeutics, Inc.
- Balance sheet
Panbela Therapeutics, Inc. (PBLA) Balance sheet
Market cap
$4.85
P/E ratio
| 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
| Cash and cash equivalents | 110,938 | 58,822 | 163,772 | 925,000 | 438,000 | 152,000 | 1 | 2 | 9 | 12 | 1 | 3 |
| Total cash & short-term investments | 110,938 | 58,822 | 163,772 | 925,000 | 438,000 | 152,000 | 1 | 2 | 9 | 12 | 1 | 3 |
| Accounts receivable, net | 75,482 | 14,800 | 18,080 | - | - | - | - | - | - | - | - | - |
| Total current assets | 336,809 | 432,843 | 391,077 | 2 | 1 | 1 | 2 | 3 | 10 | 12 | 2 | 3 |
| Property, plant and equipment, net | 15,877 | 19,198 | 13,006 | - | - | - | - | - | - | - | - | - |
| Total assets | 610,906 | 532,261 | 407,116 | 2 | 1 | 1 | 2 | 3 | 10 | 13 | 5 | 12 |
| Accounts payable | 28,142 | 3,995 | 340 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 10 |
| Long-term debt, current | - | - | - | - | 0 | 0 | 0 | - | - | - | - | - |
| Total current liabilities | 643,504 | 663,695 | 615,662 | 1 | 6 | 4 | 2 | 2 | 1 | 3 | 8 | 12 |
| Long-term debt, non-current | - | - | - | 0 | - | 0 | - | - | - | - | 5 | 4 |
| Total non-current liabilities | - | - | - | 3 | - | 0 | - | - | - | - | 5 | 4 |
| Total liabilities | 651,753 | 670,153 | 618,075 | - | - | - | - | 2 | 1 | 3 | 13 | 17 |
| Retained earnings | -13,669,971 | -13,881,992 | -13,989,036 | -14 | -19 | -29 | -35 | -41 | -46 | -56 | -91 | -125 |
| Stockholders' equity | -40,847 | -137,892 | -210,959 | -3 | -5 | -4 | 0 | 1 | 8 | 10 | -8 | -5 |